Results 21 to 30 of about 1,678,519 (353)
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study [PDF]
Intestinal Research, 2021 Background/Aims The efficacy and safety of vedolizumab in moderate to severely active ulcerative colitis (UC) have been demonstrated in the GEMINI 1 study (NCT00783718).
Choon Jin Ooi +7 more
doaj +1 more source
Journal of Nepal Medical Association, 2021 Introduction: Treatment of lupus nephritis consists of six months of induction immunosuppression followed by years of maintenance immunosuppression.
Shailendra Shrestha, Rahul Yadav
doaj +1 more source
EClinicalMedicine, 2020 Background: The therapeutic role of methotrexate (MTX) for management of inflammatory bowel disease (IBD) remains unclear. Methods: We systematically reviewed randomized, controlled trials (RCTs) of MTX for induction and maintenance of remission in IBD ...
Ole Haagen Nielsen +3 more
doaj +1 more source
Infection during remission induction in childhood leukaemia [PDF]
Archives of Disease in Childhood, 1980 We have analysed our experience in the management of suspected infection in a group of 221 children with acute leukaemia undergoing induction of first remission. Patients with suspected infection received early empirical antibiotic therapy with cephalothin and gentamicin pending results of bacteriological investigations.
J M, Chessells, A D, Leiper
openaire +2 more sources
A case of regression of atypical dense deposit disease without C3 deposition in a child [PDF]
Korean Journal of Pediatrics, 2010 Dense deposit disease (DDD) is a rare disorder characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidneys. The diagnosis is made in most patients between 5 and 15 years of age, and within 10
Min Sun Kim +3 more
doaj +1 more source
Presse medicale, 2020 Treatment of vasculitides associated with anti-neutrophil cytoplasm antibodies (ANCA) (AAVs) has evolved dramatically in recent years, particularly since the demonstration of rituximab efficacy as remission induction and maintenance therapy for ...
B. Terrier +16 more
semanticscholar +1 more source
Natalizumab for induction of remission in Crohn's disease [PDF]
Cochrane Database of Systematic Reviews, 2018 This systematic review update summarizes the current evidence on the use of natalizumab for induction of remission in Crohn's disease (CD).To determine the efficacy and safety of natalizumab for induction of remission in CD.We searched MEDLINE, Embase, CENTRAL, the Cochrane IBD Group Specialized Trials Register, and clinicaltrials.gov from inception to
Seana Ml, Nelson +3 more
openaire +2 more sources
Methotrexate for induction of remission in ulcerative colitis [PDF]
Cochrane Database of Systematic Reviews, 2014 Ulcerative colitis (UC) is a chronic inflammatory bowel disease. Corticosteroids and 5-aminosalicylates are the most commonly used therapies. However, many patients require immunosuppressive therapy for steroid-refractory and steroid-dependent disease.
Nilesh, Chande +3 more
openaire +2 more sources
Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia. [PDF]
, 2019 Optimization of post-remission therapies to maintain complete remission and prevent relapse is a major challenge in treating patients with acute myeloid leukemia (AML).
Chan, Steven M +4 more
core +1 more source
Detection of monosomy 7 in interphase cells of patients with myeloid disorders [PDF]
, 1990 Six patients, five with acute myeloid leukemia (AML) and one with a myelodysplastic syndrome (MDS), were found to have monosomy 7 by conventional cytogenetics at diagnosis.
Cremer, Thomas +5 more
core +1 more source